Table 1.
Correlation between clinicopathological factors and serum indicators of systemic inflammatory response.
| Clinicopathological Parameters | Number n = 1052 (%) | NLR | p Value | LMR | p Value * | |||
|---|---|---|---|---|---|---|---|---|
| <3.11 (23.9%) | ≥3.11 (76.1%) | <3.39 (82.0%) | ≥3.39 (18.0%) | |||||
| Gender | Male | (61.9) | (56.1) | (63.7) | 0.05 | (64.6) | (50.0) | 0.001 |
| Female | (38.1) | (43.9) | (36.3) | (35.4) | (50.0) | |||
| Age (years) | <60 | (30.8) | (26.0) | (32.3) | 0.09 | (30.8) | (30.4) | 0.92 |
| ≥60 | (69.2) | (74.0) | (67.7) | (69.2) | (69.6) | |||
| Tumor location | Low | (25.2) | (14.8) | (27.0) | 0.01 | (28.2) | (7.7) | 0.0001 |
| Mid/upper | (74.8) | (85.2) | (73.0) | (71.8) | (92.3) | |||
| Depth of infiltration | pT1-2 | (31.2) | (28.2) | (32.2) | 0.30 | (32.7) | (24.3) | 0.05 |
| pT3-4 | (68.8) | (71.8) | (67.8) | (67.3) | (75.7) | |||
| Lymph node status | pN0 | (58.2) | (60.0) | (50.0) | 0.02 | (60.0) | (50.0) | 0.02 |
| pN+ | (41.8) | (40.0) | (50.0) | (40.0) | (50.0) | |||
| Sphincter-preserving | Yes | (70.5) | (83.2) | (66.6) | 0.0001 | (67.9) | (82.4) | 0.0001 |
| No | (29.5) | (16.8) | (33.4) | (32.1) | (17.6) | |||
| Preoperative oncologic therapy | Yes | (62.0) | (30.6) | (71.8) | 0.0001 | (68.0) | (34.5) | 0.0001 |
| No | (38.0) | (69.4) | (28.2) | (32.0) | (65.5) | |||
(NLR = neutrophil-to-lymphocyte ratio; LMR = lymphocyte-to-monocyte ratio; * Chi square test).